查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1325319

全球乳铁蛋白市场 - 2023-2030

Global Lactoferrin Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 102 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球乳铁蛋白市场在 2022 年达到 3.623 亿美元，预计到 2030 年将实现利润丰厚的增长，达到 6.413 亿美元。在 2023-2030 年预测期内，该市场的复合年增长率为 7.4%。

消费者对膳食补充剂和具有特定健康益处的功能性食品的兴趣正在上升。由于其具有增强免疫力、促进肠道健康和抗氧化特性，乳铁蛋白被用于功能性食品和补充剂产品中。消费者预计会更频繁地使用富含乳铁蛋白的产品，因为他们正在寻找天然且实用的方法来增强整体健康和福祉。

例如，2023 年 3 月 17 日，FrieslandCampina Ingredients 在荷兰费赫尔建造了一座新的乳铁蛋白生产工厂，以帮助满足全球婴儿和成人营养行业不断增长的需求。该工厂将公司的总产能从每年 20 吨提高到 80 吨。

市场动态

不断增长的婴儿人口正在推动乳铁蛋白市场的增长

全球许多国家的出生率不断上升，导致新生儿人口增加。由于人口扩张、医疗设施增加和社会经济动态变化，出生率不断上升。据联合国统计，每天有 385,000 名新生儿出生。每年，这一金额超过 1.4 亿美元。随着越来越多的婴儿出生，对婴儿餵养产品的需求不断增加，尤其是含有乳铁蛋白的婴儿餵养产品。

虽然母乳喂养被认为是婴儿最健康的营养来源，但从母乳喂养转向配方奶餵养的情况发生了重大转变，尤其是在城市。这种趋势可能归因于多种因素，例如职业母亲数量的增加、生活方式的改变和文化影响。因此，随着越来越多的婴儿依赖配方奶餵养，对婴儿配方奶粉（尤其是富含乳铁蛋白的配方奶粉）的需求也在增长。

人们对乳铁蛋白健康益处的认识不断提高正在推动乳铁蛋白市场的增长

乳铁蛋白因其增强免疫功能的潜力而受到认可。人们发现它通过支持淋巴细胞和自然杀伤细胞等免疫细胞的产生和活动对免疫系统产生积极影响。此外，乳铁蛋白与铁结合的能力可抑制细菌和病毒的生长，表现出抗菌特性。随着人们对免疫健康的日益关注，乳铁蛋白被认为是免疫支持补充剂和功能性食品的宝贵成分。

乳铁蛋白在维持肠道健康方面发挥着重要作用。它通过促进双歧桿菌和乳酸桿菌等有益细菌的生长，同时抑制有害细菌的生长，帮助调节肠道微生物群。乳铁蛋白具有抗氧化活性，有助于对抗氧化压力并降低与炎症相关的慢性疾病的风险。随着人们越来越意识到炎症在各种健康状况中的作用，乳铁蛋白的抗炎功效有助于其市场增长。

监管和知识产权问题可能会阻碍乳铁蛋白市场的增长

监管机构为含有乳铁蛋白的食品和药品製定了严格的安全和质量标准。遵守这些标准通常需要严格的测试、可追溯性和质量控制措施。满足这些标准可能成本高昂且耗时，特别是对于可能缺乏必要资源和专业知识的小规模生产商而言。

专利和知识产权在乳铁蛋白市场中发挥着至关重要的作用。知识产权保护对于投资乳铁蛋白产品研发的製造商至关重要。然而，应对知识产权的复杂性可能具有挑战性，而且专利纠纷可能会阻碍创新和市场增长。

COVID-19 影响分析

COVID-19 分析包括新冠疫情前情景、新冠疫情情景和新冠疫情后情景以及定价动态（包括与新冠疫情前情景相比的大流行期间和大流行后的价格变化）、供需谱（需求和供应变化）供应由于贸易限制、封锁和后续问题）、政府倡议（政府机构振兴市场、部门或行业的倡议）和製造商战略倡议（此处将介绍製造商为缓解新冠疫情问题所做的努力）。

目录

第 1 章：方法和范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义和概述

第 3 章：执行摘要

  • 来源片段
  • 按应用程序片段
  • 按最终用途分類的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 不断增长的婴儿人口
      • 提高对乳铁蛋白健康益处的认识
    • 限制
      • 监管和知识产权问题
    • 机会
      • 对功能性成分的需求不断增长
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商战略倡议
  • 结论

第 7 章：按来源

  • 牛奶
  • 工程大米
  • 猪奶
  • 母乳
  • 鼠奶
  • 其他的

第 8 章：按应用

  • 免疫健康
  • 口腔卫生
  • 肠道健康
  • 皮肤护理
  • 其他的

第 9 章：按最终用途

  • 功能性食品和饮料
  • 膳食补充剂
  • 婴幼儿配方奶粉
  • 化妆品
  • 其他的

第 10 章：按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • MILEI GmbH
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Farbest Brands
  • Synlait Ltd.
  • Glanbia Plc.
  • Bega Bionutrients
  • Saputa Dairy Australia Pty Ltd.
  • Forterra Co-Operative Group
  • Armor Proteins
  • Hilmar Cheese Company, Inc.
  • Conagen, Inc.

第 13 章：附录

简介目录
Product Code: FB3711

Market Overview

Global Lactoferrin Market reached US$ 362.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 641.3 million by 2030. The market is growing at a CAGR of 7.4% during the forecast period 2023-2030.

Consumer interest in dietary supplements and functional foods with specific health benefits is rising. Because of its immune-boosting, gut-health-promoting, and antioxidant properties, lactoferrin is used in functional food and supplement products. Customers are anticipated to use lactoferrin-enriched goods more frequently as they look for natural and practical ways to enhance their overall health and well-being.

For instance, On March 17, 2023, FrieslandCampina Ingredients built a new lactoferrin production plant in Veghel, Netherlands, to assist fulfill rising worldwide demand in the infant and adult nutrition industries. The facility boosts the company's total capacity from 20 to 80 metric tonnes per year.

Market Dynamics

The Rising Infant Population is Driving the Market Growth of Lactoferrin

The global birth rate has been increasing in many countries, resulting to an increase in the newborn population. Birth rates are rising as a result of population expansion, increased healthcare facilities, and altering socioeconomic dynamics. Every day, 385,000 newborns are born, according to the United Nations. Every year, this amounts to more than 140 million dollars. As more babies are born, there is an increased need for baby feeding products, particularly those containing lactoferrin.

While breastfeeding is thought to be the healthiest source of nutrition for babies, there is a significant shift away from breastfeeding and towards formula feeding, particularly in cities. This tendency may be attributed to a number of factors such as an increase in the number of working mothers, lifestyle changes, and cultural influences. As a result, as more babies rely on formula feeding, the need for baby formula options, particularly lactoferrin-enriched formula, grows.

Increased Awareness of Lactoferrin's Health Benefits is Driving Lactoferrin Market Growth

Lactoferrin is recognized for its potential in enhancing immune function. It has been found to have a positive impact on the immune system by supporting the production and activity of immune cells like lymphocytes and natural killer cells. Additionally, lactoferrin's ability to bind to iron inhibits the growth of bacteria and viruses, displaying antimicrobial properties. With growing concerns over immune health, lactoferrin is being recognized as a valuable ingredient for immune-supporting supplements and functional foods.

Lactoferrin plays a role in maintaining a healthy gut. It helps regulate the gut microbiota by promoting the growth of beneficial bacteria like bifidobacteria and lactobacilli while inhibiting the growth of harmful bacteria. Lactoferrin exhibits antioxidant activity, which helps combat oxidative stress and reduce the risk of chronic diseases associated with inflammation. As people become more conscious of the role of inflammation in various health conditions, lactoferrin's anti-inflammatory benefits contribute to its market growth.

Regulatory and Intellectual Property Issues can Hamper the Growth of the Lactoferrin Market

Regulatory authorities set stringent safety and quality standards for food and pharmaceutical products containing lactoferrin. Compliance with these standards often requires rigorous testing, traceability, and quality control measures. Meeting these standards can be costly and time-consuming, especially for small-scale producers who may lack the necessary resources and expertise.

Patents and intellectual property rights play a crucial role in the lactoferrin market. The protection of intellectual property is essential for manufacturers investing in the research and development of lactoferrin-based products. However, navigating the complexities of intellectual property rights can be challenging, and patent disputes can impede innovation and market growth.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global lactoferrin market is segmented based on source, application, end-use, and region.

Abundance of 2'-Fucosyllactose (2'FL) in Human Milk

In 2022, based on the source, bovine lactoferrin held the highest share of the lactoferrin market. Bovine milk is a readily available source of lactoferrin. The dairy industry produces a significant amount of bovine milk, allowing for a consistent and ample supply of bovine lactoferrin. In August 2022, TurtleTree, a biotech company, declared its production of LF + , the world's first sustainable bovine lactoferrin created using precision fermentation technology.

Bovine lactoferrin shares structural and functional similarities with human lactoferrin, making it a suitable substitute in various applications. It exhibits similar immune-enhancing and antimicrobial properties, which are desirable characteristics in products that incorporate lactoferrin. These features encourage producers to supply fresh bovine lactoferrin products, which has boosted market share.

Geographical Analysis

Growing Health Consciousness in North America Regions

In 2022, the North American region had a significant share of the lactoferrin market. The region's healthcare infrastructure possesses advanced medical facilities, research institutes, and pharmaceutical companies, establishing favorable conditions for the progress, manufacturing, and dissemination of products incorporating lactoferrin.

The North American market has witnessed a growing interest in functional foods, dietary supplements, and nutraceuticals. For instance, according to the Centers for Disease Control and Prevention, in 2021, data from the National Health and Nutrition Examination Survey, showed that 57.6%of the US adults of age 20 and over, used dietary supplements. Consumers in this region are increasingly seeking products that offer health benefits beyond basic nutrition. Lactoferrin, with its potential immune-enhancing and gut health properties, aligns well with this trend, driving its demand in the market.

Competitive Landscape

The major global players include MILEI GmbH, Farbest Brands, Synlait Ltd., Glanbia Plc., Bega Bionutrients, Saputa Dairy Australia Pty Ltd., Forterra Co-Operative Group, Armor Proteins, Hilmar Cheese Company, Inc., Conagen, Inc.

Why Purchase the Report?

  • To visualize the global lactoferrin market segmentation based on source, application, end-use, and region understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of Lactoferrin market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The Global Lactoferrin Market Report Would Provide Approximately 61 Tables, 64 Figures, and 102 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-Use
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Rising Infant Population
      • 4.1.1.2. Increased Awareness of Lactoferrin's Health Benefits
    • 4.1.2. Restraints
      • 4.1.1.2. Regulatory and Intellectual Property Issues
    • 4.1.3. Opportunity
      • 4.1.2.1. Rising Demand for Functional Ingredients
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Source

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 7.1.2. Market Attractiveness Index, By Source
  • 7.2. Bovine Milk *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Engineered Rice
  • 7.4. Porcine Milk
  • 7.5. Human Milk
  • 7.6. Murine Milk
  • 7.7. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Immune Health*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Oral Hygiene
  • 8.4. Gut Health
  • 8.5. Skin Care
  • 8.6. Others

9. By End-Use

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 9.1.2. Market Attractiveness Index, By End-Use
  • 9.2. Functional Foods & Drinks*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dietary Supplements
  • 9.4. Infant Formula
  • 9.5. Cosmetics
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Use

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. MILEI GmbH*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Farbest Brands
  • 12.3. Synlait Ltd.
  • 12.4. Glanbia Plc.
  • 12.5. Bega Bionutrients
  • 12.6. Saputa Dairy Australia Pty Ltd.
  • 12.7. Forterra Co-Operative Group
  • 12.8. Armor Proteins
  • 12.9. Hilmar Cheese Company, Inc.
  • 12.10. Conagen, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us